Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Keigher, C.
Right arrow Articles by Dunne, F.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Treating to target in type 2 diabetes

Carol Keigher

Department of Medicine, University College Hospital (UCHG) and National University of Ireland Galway (NUIG)

Gloria Avalos

Department of Medicine, University College Hospital (UCHG) and National University of Ireland Galway (NUIG)

Fidelma Dunne

Department of Medicine, University College Hospital (UCHG) and National University of Ireland Galway (NUIG), Fidelma.dunne{at}nuigalway.ie

Patients with type 2 diabetes have a three-fold increased risk of developing vascular disease with death in 75% due to a vascular complication. Large prospective studies have demonstrated the benefits of treating patients with type 2 diabetes to strict targets regarding blood pressure (BP), lipids and glucose. Using both American Diabetes Association and Joint British Societies/Guidelines we assessed the effectiveness of this `treat-to-target' policy in diabetic patients attending secondary care. Of 321 patient notes analysed 54—87% were within target for total cholesterol, 80—84% for LDL cholesterol, 77% for HDL cholesterol, 51% for triglycerides, 44—61% for systolic BP, 62% for diastolic BP and 30—44% for HbA1C. In the secondary care setting we are performing well for lipids, less well for BP and poorly for HbA1C.

Key Words: type 2 diabetes • blood pressure • lipids • glycaemic control.

The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 2, 83-85 (2007)
DOI: 10.1177/14746514070070020601
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?